ロード中...
Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
Hydralazine and nitrate combination was the first treatment that showed improved survival of patients with heart failure with reduced left ventricular ejection fraction (HFREF) in the Vasodilator Heart Failure Trial (V‐HeFT trial) in 1986. This showed a 34% reduction of mortality at 2 years of follo...
保存先:
| 出版年: | ESC Heart Fail |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6676279/ https://ncbi.nlm.nih.gov/pubmed/31119890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12459 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|